UK Markets open in 4 hrs 19 mins

Hikma Pharmaceuticals PLC (HIK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
2,601.00+1.00 (+0.04%)
At close: 4:35PM GMT
Currency in GBp

Valuation measures

Market cap (intra-day) 56B
Enterprise value 36.83B
Trailing P/E 12.32
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)2.62
Price/book (mrq)334.75
Enterprise value/revenue 32.98
Enterprise value/EBITDA 611.12

Trading information

Stock price history

Beta (5Y monthly) 0.01
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 32,768.00
52-week low 31,596.00
50-day moving average 32,607.29
200-day moving average 32,438.48

Share statistics

Avg vol (3-month) 3587.67k
Avg vol (10-day) 3713.1k
Shares outstanding 5230.5M
Float 173.93M
% held by insiders 128.57%
% held by institutions 140.12%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.24
Forward annual dividend yield 40.92%
Trailing annual dividend rate 30.46
Trailing annual dividend yield 30.02%
5-year average dividend yield 41.54
Payout ratio 422.27%
Dividend date 3N/A
Ex-dividend date 420 Aug 2020
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2019
Most-recent quarter (mrq)30 Jun 2020

Profitability

Profit margin 22.38%
Operating margin (ttm)22.25%

Management effectiveness

Return on assets (ttm)8.42%
Return on equity (ttm)27.46%

Income statement

Revenue (ttm)2.29B
Revenue per share (ttm)9.47
Quarterly revenue growth (yoy)8.10%
Gross profit (ttm)1.09B
EBITDA 614M
Net income avi to common (ttm)513M
Diluted EPS (ttm)211.10
Quarterly earnings growth (yoy)14.60%

Balance sheet

Total cash (mrq)436M
Total cash per share (mrq)1.79
Total debt (mrq)927M
Total debt/equity (mrq)48.79
Current ratio (mrq)1.75
Book value per share (mrq)7.77

Cash flow statement

Operating cash flow (ttm)572M
Levered free cash flow (ttm)349M